Its presence is not specific for RA (Thompson et al, 1999)
Another user throws away perfectly good GHK-Cu at day 20 thinking it expired
CV outcomes for adult patients with type 2 diabetes and established cardiovascular disease LEADERa landmark CVOT for Victoza 1 9,340 patients Key inclusion criteria: T2D, A1C 7.0% Age 50 years and established CVD OR Age 60 years and risk factors for CVD Cardiovascular standards of care (antihypertensives, lipid-lowering agents, and antiplatelet therapy) Diabetes standards of care (lifestyle modification, OADs, and insulin) Duration 3.5-5 years Time to first major adverse cardiovascular event (MACE) composed of: Composite primary endpoint CV death Nonfatal MI Nonfatal stroke Prospectively designed and powered to assess noninferiority and then superiority Patients were titrated to maximum tolerated dose of 0.6 mg to 1.8 mg Median daily dose of Victoza was 1.78 mg Victoza significantly reduced MACE in adults with T2D and established CVD 1 Absolute risk reduction: 1.9% Median time of exposure to treatment: 3.5 years
Colleagues debating whether GLP-1s belong in psychiatric practice
Copper Peptide GHK-Cu for Hair Growth: Emerging Data Hair applications stem from GHK-Cus follicle stimulation
Rehydration Drip If youre feeling dehydrated after illness, travel, or intense activity, our Rehydration Drip replenishes lost fluids and electrolytes quickly, restoring balance and preventing fatigue or dizziness
